J. Kára
- Topics
- Biochemical and Molecular Research (8 papers)Virus-based gene therapy research (5 papers)Click Chemistry and Applications (4 papers)
- Journals
- Proceedings of the National Academy of SciencesBiochemical and Biophysical Research CommunicationsFEBS Letters
- Partner nations
- CzechiaUnited Kingdom
In The Last Decade
J. Kára
35 papers receiving 258 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 209
- Oncology 59
- Genetics 58
- Epidemiology 46
- Animal Science and Zoology 44
Countries citing papers authored by J. Kára
This map shows the geographic impact of J. Kára's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kára with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kára more than expected).
Fields of papers citing papers by J. Kára
This network shows the impact of papers produced by J. Kára. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kára. The network helps show where J. Kára may publish in the future.
Co-authorship network of co-authors of J. Kára
This figure shows the co-authorship network connecting the top 25 collaborators of J. Kára. A scholar is included among the top collaborators of J. Kára based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kára. J. Kára is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions. | 3 |
| 2 | A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL. | 13 |
| 3 | 3 | |
| 4 | 14 | |
| 5 | Antileukaemic and antiviral effect of chloramphenicol and rifampicin combination in the therapy of Rauscher murine leukaemia. | 2 |
| 6 | 40 | |
| 7 | Presence of group-specific antigen of avian sarcoma leukosis complex in subcellular fractions of tumours induced by Schmidt-Ruppin strain of Rous sarcoma virus. | 1 |
| 8 | Enhancement of antibody synthesis in vitro by 6-azauridine, uridine and actinomycin D. | 1 |
| 9 | 6 | |
| 10 | 10 | |
| 11 | Induction of deoxycytidylate deaminase and uridine kinase and activation of cellular DNA synthesis in the course of transformation of chicken embryo cells infected by Rous sarcoma virus in vitro. | 5 |
| 12 | 2 | |
| 13 | 8 | |
| 14 | Determination of uridine kinase activity in some human tumours and in leucaemic cells using 4,5-C-14--azauridine as substrate. | 1 |
| 15 | 4 | |
| 16 | 2 | |
| 17 | 4 | |
| 18 | 10 | |
| 19 | 28 | |
| 20 | 2 |
About J. Kára
J. Kára is a scholar working on Animal Science and Zoology, Molecular Biology and Clinical Biochemistry, having authored 36 papers that have together received 303 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (8 papers), Virus-based gene therapy research (5 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Animal Science and Zoology (44 citations), Molecular Biology (209 citations) and Physiology (10 citations). J. Kára has collaborated with scholars based in Czechia and United Kingdom. Frequent co-authors include O Mach, Robert Weil, F. Šorm, H Cerná, Roger Weil, J. Škoda, Z. Šormová, Antonı́n Holý, M Dvořák and Karel Ubik. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.